EZH2 Mutations in Follicular Lymphoma from Different Ethnic Groups and Associated Gene Expression Alterations

被引:36
作者
Guo, Shuangping [1 ,7 ]
Chan, John K. C. [2 ]
Iqbal, Javeed [7 ]
McKeithan, Timothy [7 ]
Fu, Kai [7 ]
Meng, Bin [3 ]
Pan, Yi [4 ]
Cheuk, Wah [2 ]
Luo, Donglan [5 ,6 ]
Wang, Ruian [1 ]
Zhang, Weiwei [7 ]
Greiner, Timothy C. [7 ]
Chan, Wing C. [7 ]
机构
[1] Fourth Mil Med Univ, Xi Jing Hosp, Dept Pathol, Xian 710032, Shaan Xi Provin, Peoples R China
[2] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[3] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Shandong, Peoples R China
[4] Tianjin Canc Hosp, Dept Pathol, Tianjin, Peoples R China
[5] Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[6] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
[7] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
关键词
NON-HODGKIN-LYMPHOMA; B-CELL LYMPHOMAS; METHYLATION; CLL;
D O I
10.1158/1078-0432.CCR-13-1597
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Gain-of-function mutations of enhancer of Zeste homolog 2 (EZH2) occur frequently in diffuse large B-cell lymphomas and in follicular lymphomas. However, the frequency of EZH2 mutation in Chinese follicular lymphomas and the potential targets affected by this mutation are unknown. Experimental Design: We determined EZH2 codon 641 mutations in Chinese follicular lymphomas (n = 124) and compared them with Western follicular lymphomas (n = 70) using a sensitive pyrosequencing assay. Gene expression profiling (GEP) was performed to determine differential gene expression between the mutated versus unmutated subgroups, and selected genes were validated using immunohistochemistry. Results: Our results showed similar frequencies of EZH2 codon 641 mutations in Chinese and Western follicular lymphoma cohorts (16.9% vs. 18.6%, chi(2) test, P = 0.773), including all five reported mutation variants. We observed significant association of EZH2 mutation with low morphologic grade follicular lymphomas (grade 1-2, 23.6% vs. grade 3, 7.7%, chi(2) test, P = 0.02). EZH2 mutations also showed significant association with BCL2 rearrangement in the Chinese cohort (26.8% vs. 8.8%, chi(2) test, P = 0.008) and combined cohorts (26.3% vs. 9.1%, chi(2) test, P = 0.002). GEP analysis identified several genes, including TCF4, FOXP1, TCL1A, BIK, and RASSF6P, with significantly lower mRNA expression (P < 0.01) in mutated cases, and the potential target TCL1A showed consistent results at the protein level. Conclusion: Similar prevalence of EZH2 mutation in two ethnic groups suggests shared pathogenetic mechanisms. The much lower frequency of EZH2 mutation in cases without BCL2 translocation suggests a different pattern of evolution of this subtype of follicular lymphoma. GEP studies showed a set of differentially expressed genes and suggested that EZH2 mutation may help to lock the tumor cells at the germinal center stage of differentiation. (C) 2014 AACR.
引用
收藏
页码:3078 / 3086
页数:9
相关论文
共 20 条
[1]   TCL1A expression delineates biological and clinical variability in B-cell lymphoma [J].
Aggarwal, Mohit ;
Villuendas, Raquel ;
Gomez, Gonzalo ;
Rodriguez-Pinilla, Socorro M. ;
Sanchez-Beato, Margarita ;
Alvarez, David ;
Martinez, Nerea ;
Rodriguez, Antonia ;
Castillo, Maria E. ;
Camacho, Francisca I. ;
Montes-Moreno, Santiago ;
Garcia-Marco, Jose A. ;
Kimby, Eva ;
Pisano, David G. ;
Piris, Miguel A. .
MODERN PATHOLOGY, 2009, 22 (02) :206-215
[2]   Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations [J].
Anderson, JR ;
Armitage, JO ;
Weisenburger, DD .
ANNALS OF ONCOLOGY, 1998, 9 (07) :717-720
[3]   Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001-2006 [J].
Aoki, Ryosuke ;
Karube, Kennosuke ;
Sugita, Yasuo ;
Nomura, Yuko ;
Shimizu, Kay ;
Kimura, Yoshizo ;
Hashikawa, Keiko ;
Suefuji, Nobuko ;
Kikuchi, Masahiro ;
Ohshima, Koichi .
PATHOLOGY INTERNATIONAL, 2008, 58 (03) :174-182
[4]   EZH2 Y641 mutations in follicular lymphoma [J].
Boedoer, C. ;
O'Riain, C. ;
Wrench, D. ;
Matthews, J. ;
Iyengar, S. ;
Tayyib, H. ;
Calaminici, M. ;
Clear, A. ;
Iqbal, S. ;
Quentmeier, H. ;
Drexler, H. G. ;
Montoto, S. ;
Lister, A. T. ;
Gribben, J. G. ;
Matolcsy, A. ;
Fitzgibbon, J. .
LEUKEMIA, 2011, 25 (04) :726-729
[5]   A Microarray Platform-Independent Classification Tool for Cell of Origin Class Allows Comparative Analysis of Gene Expression in Diffuse Large B-cell Lymphoma [J].
Care, Matthew A. ;
Barrans, Sharon ;
Worrillow, Lisa ;
Jack, Andrew ;
Westhead, David R. ;
Tooze, Reuben M. .
PLOS ONE, 2013, 8 (02)
[6]   Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways [J].
Dybkaer, Karen ;
Iqbal, Javeed ;
Zhou, Guimei ;
Geng, Huimin ;
Xiao, Li ;
Schmitz, Alexander ;
d'Amore, Francesco ;
Chan, Wing C. .
BMC GENOMICS, 2007, 8 (1)
[7]   Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications [J].
Hatzimichael, Eleftheria ;
Dasoula, Aggeliki ;
Kounnis, Valentinos ;
Benetatos, Leonidas ;
Lo Nigro, Cristiana ;
Lattanzio, Laura ;
Papoudou-Bai, Alexandra ;
Dranitsaris, George ;
Briasoulis, Evangelos ;
Crook, Tim .
LEUKEMIA & LYMPHOMA, 2012, 53 (09) :1709-1713
[8]   The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias [J].
Hesson, Luke B. ;
Dunwell, Thomas L. ;
Cooper, Wendy N. ;
Catchpoole, Daniel ;
Brini, Anna T. ;
Chiaramonte, Raffaella ;
Griffiths, Mike ;
Chalmers, Andrew D. ;
Maher, Eamonn R. ;
Latif, Farida .
MOLECULAR CANCER, 2009, 8
[9]  
Huh Jooryung, 2012, Korean J Hematol, V47, P92, DOI 10.5045/kjh.2012.47.2.92
[10]   Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases [J].
Laurini, Javier A. ;
Perry, Anamarija M. ;
Boilesen, Eugene ;
Diebold, Jacques ;
MacLennan, Kenneth A. ;
Mueller-Hermelink, H. Konrad ;
Nathwani, Bharat N. ;
Armitage, James O. ;
Weisenburger, Dennis D. .
BLOOD, 2012, 120 (24) :4795-4801